How the prevalence of breast carcinoma in women changed over 2009-2017, its stage and grade in young females in Iraqi city, Kerbala
Keywords:
Key words: breast carcinoma, prevalence, young women, stage and grade.Abstract
Background: Breast cancer is the most common malignancy in females in general and it constitutes about one fourth of cancer cases in Iraq. In Iraq, there was a noticed increase in cancer cases after the series of wars and conflicts during the last two decades and breast cancer is an important one of them. Aim : the goal of this study is to follow the trends in breast cancer prevalence over the last nine years in Kerbala , to make a focus on the percentage of cases that occur in young and its characters. Materials and methods: the data are collected from AL-Hussein teaching hospital in Kerbala . the prevalence among general population and young females(≤ 40) over 2009-2017 was interpreted using descriptive statistics while staging and grading characters and their relation to the age was analyzed using Chi square program and p value. Results : annual increase in the number of cases was found over 2009-2017 with highest prevalence in 2016 (91 case).The mean for age was 50.7 and SD of 13.7. There was no significant difference in the percentage of young female carcinoma cases over the years but there was fluctuation in the percentage with highest value in 2010 (43.7%). Young women breast cancer constitute 24%(95 case) from the total cases over the studied years (395 case). Both grade III and stage III present at higher percentage in young female than old (23% vs. 5.9% for grade III and 50% vs. 30.5 for stage III), the results were near but did not reach the significant level statistically ( p value 0.06, 0.07 respectively). Conclusion: the prevalence of breast carcinoma is increasing in Kerbala over the` years 2009-2017 with higher percentage is noted in young females than other developed countries and breast cancer in young female present at somewhat higher grade and stage. We recommend more studies about the causes of breast cancer dissemination in the population and to start screening program at an earlier age ( > 40 year.)
Key words: breast carcinoma, prevalence, young women, stage and grade.
References
2. International Agency for Research on Cancer (2010). Globocan 2008. World Cancer Statistics. Lyon, IARC Press. Available at: http:// globocan.iarc.fr/ factsheets /popul- ations / factsheet. aspuno=900.
3. Boyle P, Howell A. The globalisation of breast cancer. Breast Cancer Res 2010;12 Suppl 4:S7.
4. Fredholm H, Eaker S, Frisell J, et al. Breast cancer in young women: poor survival despite intensive treatment. PLoS One 2009;4:e7695.
5. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A: Breast cancer before age 40 years. Semin Oncol 2009, 36:237-249.
6. Hussein A. Assi, Katia E. Khoury, Haifa Dbouk, et al. Epidemiology and prognosis of breast cancer in young women. J Thorac Dis 2013;5(S1):S2-S8. doi: 10.3978/j.issn.2072-1439.2013.05.24.
7. Alwan N (2010). Breast Cancer: Demographic Characteristics and Clinico-pathological Presentation of Patients in Iraq. Eastern Mediterranean Health Journal, 16:1073–1078.
8. Alwan NAS (2000). DNA proliferative index as a marker in Iraqi aneuploid mammary carcinoma. Eastern Mediterranean Health Journal, 6:1062–1072
9. Courtney A Gabriel1 and Susan M Domchek. Breast cancer in young women. Gabriel and Domchek Breast Cancer Research 2010, 12:212.
10. Han W, Kim SW, Park IA, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 2004;4:82.
11. Colleoni M, Rotmensz N, Robertson C et al. : Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002, 13:273-279
12. Birch JM, Hartley AL, Tricker KJ, et al.: Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994, 54:1298-1304.
13. Muzahem Mohammed Yahya AL-Hashimi , Xiang Jung Wang. Breast Cancer in Iraq, Incidence Trends from 2000-2009. Asian Pacific Journal of Cancer Prevention, Vol 15, 2014.
14. Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA: Breast cancers among very young premenopausal women (United States). Cancer Causes Control 2003,14:151-160
15- Al-Shammari AM. ( Environmental pollutions associated to conflicts in Iraq and related health problems). Rev Environ Health. 2016 Jun 1;31(2):245-50.
16. Mark F. Miller,1 William H. Goodson III,2 Masoud H. Manjili et al. Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations. Environmental Health Perspectives • volume 125 | number 2 | February 2017.
17. Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins G, et al. 2002. Summary of the National Toxicology Program’s report of the endocrine disruptors low dose peer review. Environ Health Perspect 110(4):427–431.
18. Goodson WH III, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, et al. 2015. Assessing the carcinogenic potential of lowdose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis 36(suppl 1):S254–S296.
19. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
20. Narod SA. Breast cancer in young women. Nat Rev Clin Oncol 2012;9:460-70.
21. Runnak A Majid1, Hemin A Hassan1, Dana N Muhealdeen1 et al. Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age. BMC Women's Health (2017) 17:27.
22. M. Colleoni1, N. Rotmensz, C. Robertson et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation. Annals of Oncology 13: 273–279, 2002.
23. Pinder SE, Murray S, Ellis IO et al. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 1998; 83: 1529–1539.
24. Schumacher M, Schmoor C, Sauerbrei W et al. The prognostic effect of histological tumor grade in node-negative breast cancer patients. Breast Cancer Res Treat 1993; 25: 235–245.
25. Lundin J, Lundin M, Holli K et al. Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study. J Clin Oncol 2001; 19: 28–36
26. Turchetti D, Cortesi L, Federico M et al. BRCA1 mutations and clinicopathological features in a sample of Italian women with early onset breast cancer. Eur J Cancer 2000; 36: 2083–2089.
27. Robson M, Gilewski T, Haas B et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998; 16: 1642–1649.
28. Gajdos C, Tartter PI, Bleiweiss IJ, et al. Stage 0 to stage III breast cancer in young women. J Am Coll Surg 2000;190:523-9.
29. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 5th edition, Philadelphia, PA: Lippincott-Raven; 1997; 171–180.
